These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 3117137)
1. Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Kruithof EK; Nicolosa G; Bachmann F Blood; 1987 Nov; 70(5):1645-53. PubMed ID: 3117137 [TBL] [Abstract][Full Text] [Related]
2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A; Ruusuvaara L Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043 [TBL] [Abstract][Full Text] [Related]
3. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies. Colucci M; Altomare DF; Chetta G; Triggiani R; Cavallo LG; Semeraro N Thromb Haemost; 1988 Aug; 60(1):25-9. PubMed ID: 3142090 [TBL] [Abstract][Full Text] [Related]
4. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration. Lucore CL; Fujii S; Sobel BE Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004 [TBL] [Abstract][Full Text] [Related]
5. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis. Nguyen G; Horellou MH; Kruithof EK; Conard J; Samama MM Blood; 1988 Aug; 72(2):601-5. PubMed ID: 3135860 [TBL] [Abstract][Full Text] [Related]
6. Changes in various parameters of fibrinolysis in persons infused with tissue plasminogen activator: special reference to plasminogen activator inhibitor. Takada A; Hou P; Mori T; Takada Y Thromb Res Suppl; 1988; 8():23-33. PubMed ID: 3144766 [TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Kruithof EK; Tran-Thang C; Gudinchet A; Hauert J; Nicoloso G; Genton C; Welti H; Bachmann F Blood; 1987 Feb; 69(2):460-6. PubMed ID: 2432970 [TBL] [Abstract][Full Text] [Related]
8. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Declerck PJ; Alessi MC; Verstreken M; Kruithof EK; Juhan-Vague I; Collen D Blood; 1988 Jan; 71(1):220-5. PubMed ID: 3257145 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system. Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812 [TBL] [Abstract][Full Text] [Related]
10. Measurements of the concentration of free plasminogen activator inhibitor (PAI-1) and its complex with tissue plasminogen activator in human plasma. Takada Y; Takada A Thromb Res Suppl; 1988; 8():15-22. PubMed ID: 3144765 [TBL] [Abstract][Full Text] [Related]
11. Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level. Wun TC; Capuano A Blood; 1987 May; 69(5):1354-62. PubMed ID: 3105619 [TBL] [Abstract][Full Text] [Related]
12. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541 [TBL] [Abstract][Full Text] [Related]
13. The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis. Falkon L; Garí M; Borrell M; Fontcuberta J Blood Coagul Fibrinolysis; 1992 Feb; 3(1):33-8. PubMed ID: 1623118 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor. Sakata Y; Loskutoff DJ; Gladson CL; Hekman CM; Griffin JH Blood; 1986 Dec; 68(6):1218-23. PubMed ID: 3096399 [TBL] [Abstract][Full Text] [Related]
15. Impaired fibrinolysis in coronary artery disease. Francis RB; Kawanishi D; Baruch T; Mahrer P; Rahimtoola S; Feinstein DI Am Heart J; 1988 Apr; 115(4):776-80. PubMed ID: 3128096 [TBL] [Abstract][Full Text] [Related]
16. Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications. Lucore CL; Sobel BE Circulation; 1988 Mar; 77(3):660-9. PubMed ID: 2449299 [TBL] [Abstract][Full Text] [Related]
17. Relationship between smoking and fibrinolytic system with special reference to t-PA and PA inhibitor. Hashimoto Y; Kobayashi A; Yamazaki N; Takada Y; Takada A Thromb Res; 1988 Aug; 51(3):303-11. PubMed ID: 3140409 [TBL] [Abstract][Full Text] [Related]
18. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay. Eriksson E; Rånby M; Gyzander E; Risberg B Thromb Res; 1988 Apr; 50(1):91-101. PubMed ID: 3135638 [TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator and plasminogen activator inhibitor activities in a reference population. Krishnamurti C; Tang DB; Barr CF; Alving BM Am J Clin Pathol; 1988 Jun; 89(6):747-52. PubMed ID: 3259399 [TBL] [Abstract][Full Text] [Related]